Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC is a critical drug to treat Mucormycosis or Black Fungus in India. Under the terms of the agreement,…